RACE ONCOLOGY LTD

1.27%

$1.17

Market Cap $205.0M

Healthcare Biotechnology

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a... Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care.More

Corporate Spotlight

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care.
View the full Corporate Spotlight

WEBINAR REPLAY: RACE ONCOLOGY

Latest Threads

Tag

Subject

RAC

General Comments / Chat

218 219 220

12:11

13K

4.8M

12:11

Last post Hunterr

13K

4.8M

RAC Biotech

RAC - Charts & Price Action

434 435 436

10:36

26K

9.6M

10:36

Last post tonks306511

26K

9.6M

RAC

Chat GPT Q&A

6 7 8

09/06/25

432

160K

09/06/25

Last post nextdl

432

160K

RAC

Ann: First Patient Dosed Safely in RC220 Phase 1 Trial

2 3 4

07/06/25

184

63K

07/06/25

Last post dmc

184

63K

RAC

Industry news

51 52 53

07/06/25

3.1K

1.0M

07/06/25

Last post HeyLine

3.1K

1.0M

RAC

Ann: Application for quotation of securities - RAC

06/06/25

780

06/06/25

Last post easysell

780

RAC

RAC media coverage

42 43 44

03/06/25

2.6K

927K

03/06/25

Last post Hunterr

2.6K

927K

RAC

Ann: Notification of cessation of securities - RAC

03/06/25

1.7K

03/06/25

Last post HeyLine

1.7K

RAC

Ann: Race Gold Coast Brisbane Investor Events

02/06/25

3.0K

02/06/25

Last post Hunterr

3.0K

RAC

Cardioprotection thread

18 19 20

31/05/25

1.1K

390K

31/05/25

Last post DrSanchez

1.1K

390K

RAC

Pillar 1 - FTO (new thread)

50 51 52

31/05/25

3.1K

1.1M

31/05/25

Last post HeyLine

3.1K

1.1M

RAC

Ann: Race Signs Contract for Phase 1 Trial of RC220

31/05/25

28K

31/05/25

Last post

Davisite

28K

RAC

Ann: Application for quotation of securities - RAC

29/05/25

528

29/05/25

Last post

ASX News

528

RAC

Ann: Race to Present at TechKnow July Conference

2 3

26/05/25

135

42K

26/05/25

Last post

Davisite

135

42K

RAC

Ann: Letter to Shareholders, Notice of AGM & Proxy Form

22/05/25

7.1K

22/05/25

Last post

Davisite

7.1K

RAC

Ann: Application for quotation of securities - RAC

22/05/25

714

22/05/25

Last post

ASX News

714

See All Discussions

Corporate Spotlight

ABOUT US

Timeline

Application for quotation of securities - RAC
06 Jun 11:54	Share

Notification of cessation of securities - RAC
03 Jun 10:27	Share

Race Gold Coast Brisbane Investor Events
02 Jun 12:14	Share

Application for quotation of securities - RAC
29 May 16:11	Share

Application for quotation of securities - RAC
22 May 11:14	Share

Application for quotation of securities - RAC
07 May 11:09	Share

Notification of cessation of securities - RAC
06 May 15:51	Share

Race Announces Key Senior Clinical Team Appointments
05 May 08:57	Share

First Patient Dosed Safely in RC220 Phase 1 Trial
01 May 08:57	Share

March 2025 Quarterly Activity Report and Appendix 4C
23 Apr 08:41	Share

Enrolment Opened at Second Site for RC220 Phase 1 Trial
22 Apr 08:56	Share

RC220 Phase 1 Trial Opens for Patient Enrolment
03 Apr 08:57	Share

Ethics approval for RC220 Trial at Gosford Wyong Hospitals
31 Mar 17:41	Share

Race Initiates First AU Site for Phase 1 Solid Tumour Trial
27 Mar 15:53	Share

Race Investor Presentation
17 Mar 16:53	Share

Race Online Investor Briefing Invitation
14 Mar 11:08	Share

Ethics approval received for RC220 Phase 1 Trial
14 Mar 08:47	Share

S&P DJI Announces March 2025 Quarterly Rebalance
07 Mar 17:01	Share

Race Signs Contract for Phase 1 Trial of RC220
05 Mar 08:58	Share

Appendix 4D & Half-Year Financial Statements
25 Feb 13:42	Share

Application for quotation of securities - RAC
04 Feb 13:06	Share

Quarterly Activity Report and Appendix 4C
31 Jan 08:57	Share

Application for quotation of securities - RAC
16 Jan 15:57	Share

Appendix 3X - Dr Megan Baldwin
02 Jan 08:22	Share

Race Strengthens Board
18 Dec 08:53	Share

Race Receives $5.25m RD Tax Refund for Financial Year 2024
17 Dec 10:26	Share

Race Submits Human Ethics for RC220 Phase 1 Trial
05 Dec 08:44	Share

Race 2024 Annual General Meeting Video Release
28 Nov 14:44	Share

Appendix 3Y - Dr Serge Scrofani
26 Nov 17:40	Share

Notification regarding unquoted securities - RAC
26 Nov 17:28	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.17		Change -0.015(1.27%)		Mkt cap ! $205.0M

Open	High	Low	Value	Volume
$1.19	$1.19	$1.17	$15.43K	13.05K

Buyers (Bids)

No.	Vol.	Price($)
2	1083	$1.17

Sellers (Offers)

Price($)	Vol.	No.
$1.18	348	1

View Market Depth

No.	Vol.	Price($)
3	1408	1.170
1	7556	1.165
2	2144	1.160
1	7352	1.155
3	9914	1.150

Price($)	Vol.	No.
1.180	1403	2
1.185	435	1
1.190	1641	1
1.195	5623	2
1.200	5462	2

Last trade - 13.43pm 10/06/2025 (20 minute delay)


Last $1.19		Change -0.015 ( 0.42 %)
Open	High	Low	Volume
$1.18	$1.19	$1.18	1307
Last updated 11.13am 10/06/2025 ?

RAC (ASX) Chart

RACE ONCOLOGY LTD

Corporate Spotlight

Latest Threads

AGC to Gain Belt-Scale Control of South Cobar Through Strategic Acquisition

Corporate Spotlight

Timeline

Featured News

Latest Videos

Breaking barriers in cancer treatment: Race Oncology pioneers a new era with bisantrene

14 May 2024 09:56 (AEST)

Race Oncology (ASX:RAC) strikes contracts to start observational breast cancer trial

13 Mar 2023 15:00 (AEDT)

Race Oncology (ASX:RAC) enters new collaboration investigating heart protection during chemo

02 Mar 2023 15:49 (AEDT)

Latest Articles

Race Oncology approved for Phase I trial for chemotherapeutic treatments

Race Oncology Ltd has received approval to go ahead with its Phase I trial to assess R220 and begin enrolling patients

Race identifies 39 new molecules with potential to inhibit cancer-associated protein

Race Oncology Ltd has completed a successful drug discovery program started in 2022 at Monash University in Melbourne

Race delivers promising results in cancer drug mice research into heart complications

Race Oncology (ASX:RAC) has announced a preclinical breakthrough in heart toxicity side effects caused by the carfilzomib, which had precluded the drug being administered to patients diagnosed with elevated cardiac risk factors.In work performed under contract by Labcorp in the United States, Rac...

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News